These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33336891)

  • 21. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report.
    Saltmarche AE; Naeser MA; Ho KF; Hamblin MR; Lim L
    Photomed Laser Surg; 2017 Aug; 35(8):432-441. PubMed ID: 28186867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
    Jiang H; Niu F; Zheng Y; Xu Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review.
    Monteiro F; Carvalho Ó; Sousa N; Silva FS; Sotiropoulos I
    Alzheimers Dement (N Y); 2022; 8(1):e12249. PubMed ID: 36447479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors.
    Jung H; Aman W; Hah JM
    Bioorg Med Chem Lett; 2017 May; 27(10):2139-2143. PubMed ID: 28372912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endophilin2 Interacts with GluA1 to Mediate AMPA Receptor Endocytosis Induced by Oligomeric Amyloid-
    Zhang J; Yin Y; Ji Z; Cai Z; Zhao B; Li J; Tan M; Guo G
    Neural Plast; 2017; 2017():8197085. PubMed ID: 28758034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.
    de Lemos L; Junyent F; Verdaguer E; Folch J; Romero R; Pallàs M; Ferrer I; Auladell C; Camins A
    J Neurochem; 2010 Sep; 114(5):1315-22. PubMed ID: 20534003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
    Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
    J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus.
    Tian H; Zhang QG; Zhu GX; Pei DS; Guan QH; Zhang GY
    Brain Res; 2005 Nov; 1061(1):57-66. PubMed ID: 16256962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
    Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
    Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of NgR in perforant path decreases amyloid-β peptide production and ameliorates synaptic and cognitive deficits in APP/PS1 mice.
    Jiang R; Wu XF; Wang B; Guan RX; Lv LM; Li AP; Lei L; Ma Y; Li N; Li QF; Ma QH; Zhao J; Li S
    Alzheimers Res Ther; 2020 Apr; 12(1):47. PubMed ID: 32331528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
    Yang Y; He Z; Xing Z; Zuo Z; Yuan L; Wu Y; Jiang M; Qi F; Yao Z
    J Neuroinflammation; 2020 Feb; 17(1):65. PubMed ID: 32075657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.
    Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6526-E6534. PubMed ID: 27708157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK3 couples the neuronal stress response to inhibition of secretory trafficking.
    Yang G; Zhou X; Zhu J; Liu R; Zhang S; Coquinco A; Chen Y; Wen Y; Kojic L; Jia W; Cynader MS
    Sci Signal; 2013 Jul; 6(283):ra57. PubMed ID: 23838184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.